Where does Nevakar Injectables Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Nevakar Injectables Inc. ranks #24,870 of 50,000 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Nevakar Injectables Inc. hold?

Nevakar Injectables Inc. holds 11 US utility patents granted between 2021 and 2025, spanning 4 technology areas.

What is Nevakar Injectables Inc.'s Innovation Score?

Nevakar Injectables Inc. has an Innovation Score of 45.8 out of 100 (top 22% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Nevakar Injectables Inc.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Nevakar Injectables Inc..

What does claim depth mean for Nevakar Injectables Inc.'s patents?

Nevakar Injectables Inc.'s patents average 16.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Nevakar Injectables Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Nevakar Injectables Inc.

Q: What technology areas does Nevakar Injectables Inc. focus on?

Nevakar Injectables Inc.'s top technology area is A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES) with 11 patents. Grants appear in 4 CPC subclasses total.

USPTO PatentsView assignee record - 11 granted patents across 4 technology areas, recorded in grant years 2021–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES).

Compiled by PlainPatent · May 15, 2026

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Nevakar ranks #24,870 of 50,000 tracked US assignees by granted-patent volume, with 11 patents across 4 technology areas.

#24,870
of 50,000 US assignees by volume: Top 22%
by Innovation Score (45.8/100): 16.8
avg claims per patent

USPTO PatentsView assignee plate

Corpus R24870 · US Corporation #24,870 · 11 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 11 grants
MID-PACK #24,870/50,000
PHOTO-FINISH NEOPAD
CPC-NARROW A61K · 4 areas
INNOV-PAR 45.8/100
CLAIMS-RICH 16.8 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2021–2025 · 5y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Neopad Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Nevakar Injectables · this assignee

46
3D Lighting Innovati… · lowest

7

What this shows Nevakar's Innovation Score is 45.8/100 (top 22% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Nevakar's grants concentrate

Nevakar Injectables Inc. is a focused PatentsView assignee: 4 CPC subclasses with 100% of grants classified under A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). Peak complete grant year is 2023 (4 grants) versus a trough of 1 in 2021. By volume, Nevakar sits between Neopad Inc. and Next-e Solutions Inc..

Nevakar's three-year grant acceleration

Nevakar Injectables Inc. shows 8 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Neopad

11
NestlÉ SKIN Health

11
Netsweeper (Barba…

11
Neumayer Tekfor E…

11
NEW Concepts Deve…

11
Nextteq

11
Nexus Spine

11
Next-e Solutions

11
Nevakar Injectabl… ◀

11

What this shows Nevakar holds 11 patents at rank #24,846, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Nevakar

By rank, the assignees closest to #24,846 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Nevakar's primary technology class.

Nevakar's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

46 Top 22% higher than 78% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2021–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.

View data table

Nevakar Injectables Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2021	1	9.1%
2022	2	18.2%
2023	4	36.4%
2024	2	18.2%
2025partial year	2	18.2%

Which technologies does Nevakar Injectables Inc. patent most?

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 11

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 5

Y02A - TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE 3

A61M - DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR 2

Top 4 of 4 technology areas

Where it ranks

Overall rank by patents

#24,870

of 50,000 tracked assignees

Innovation Score

45.8 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.